Findings

What do systematic reviews say?

45 questions · 56 findings · 6 reviews · Vascular

Sort:Best matchNewest Highest certainty Download CSV

No studies found 3 · 5.4%GRADE not reported 4 · 7.1%Very low 17 · 30.4%Low 19 · 33.9%Moderate 9 · 16.1%High 4 · 7.1%

Angioplasty vs primary stenting

Technical success · patients with symptomatic Iliac artery lesions

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 391 participants
Low

Angioplasty vs primary stenting

Incidence of complications (immediate) · patients with symptomatic Iliac artery lesions

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 391 participants
Low

Angioplasty vs primary stenting

Improvement in the stage of PAD according to Rutherford's criteria (one year) · patients with symptomatic Iliac artery lesions

Angioplasty showed no clear difference in improvement in the stage of PAD according to Rutherford's criteria… compared with primary stenting (low certainty).

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
OR 1.03 [0.47, 2.27]
1 study · 157 participants
Low

Angioplasty vs primary stenting

Primary patency ( · patients with symptomatic Iliac artery lesions

Angioplasty showed no clear difference in primary patency (two years) compared with primary stenting (low certainty).

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
OR 1.6 [0.34, 7.44]
1 study · 57 participants
Low

Angioplasty vs primary stenting

Reintervention · patients with symptomatic Iliac artery lesions

Angioplasty showed no clear difference in reinterventions (six to eight years) compared with primary stenting (low certainty).

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
OR 1.22 [0.67, 2.23]
1 study · 279 participants
Low

Angioplasty vs primary stenting

Resolution of symptoms and signs (one year) · patients with symptomatic Iliac artery lesions

Angioplasty showed no clear difference in resolution of symptoms and signs (one year) compared with primary stenting (low certainty).

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
OR 1.14 [0.65, 2]
1 study · 219 participants
Low

Angioplasty vs primary stenting

Improvement in walking distance as reported by the patient · patients with symptomatic Iliac artery lesions

The review found no eligible studies for this question.

1 finding from 1 review

Angioplasty versus stenting for iliac artery lesions 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Drug‐eluting balloon angioplasty at 6 months vs uncoated balloon angioplasty at 6 months

Amputation · patients with in‐stent restenosis of the femoropopliteal arteries

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the… 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 263 participants
Very low

Drug‐eluting balloon angioplasty at 6 months vs uncoated balloon angioplasty at 6 months

Target lesion revascularization · patients with in‐stent restenosis of the femoropopliteal arteries

It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes target lesion revascularization (TLR) compared with uncoated balloon angioplasty at 6 months (very low certainty).

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the… 2019 · Cochrane Headline outcomes only
OR 0.05 [0, 0.92]
1 study · 70 participants
Very low

Drug‐eluting balloon angioplasty at 6 months vs uncoated balloon angioplasty at 6 months

Binary restenosis · patients with in‐stent restenosis of the femoropopliteal arteries

It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes binary restenosis compared with uncoated balloon angioplasty at 6 months (very low certainty).

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the… 2019 · Cochrane Headline outcomes only
OR 0.28 [0.14, 0.56]
2 studies · 189 participants
Very low

Drug‐eluting balloon angioplasty at 6 months vs uncoated balloon angioplasty at 6 months

Death · patients with in‐stent restenosis of the femoropopliteal arteries

It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes death compared with uncoated balloon angioplasty at 6 months (very low certainty).

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the… 2019 · Cochrane Headline outcomes only
OR 0.93 [0.13, 6.71]
3 studies · 263 participants
Very low

Drug‐eluting balloon angioplasty at 6 months vs uncoated balloon angioplasty at 6 months

Improvement ≥ 1 Rutherford category · patients with in‐stent restenosis of the femoropopliteal arteries

It is very uncertain whether drug‐eluting balloon angioplasty at 6 months changes improvement ≥ 1 Rutherford category compared with uncoated balloon angioplasty at 6 months (very low certainty).

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in‐stent restenosis of the… 2019 · Cochrane Headline outcomes only
OR 1.81 [1.02, 3.21]
2 studies · 193 participants
Very low

Subintimal angioplasty with stenting vs remote endarterectomy

Clinical improvement: Rutherford classification improvement Rutherford classification · 95 people with Rutherford 3 to 5 TASC‐II D lesions

Subintimal angioplasty with stenting showed no clear difference in clinical improvement: Rutherford classification improvement… compared with remote endarterectomy (low certainty).

1 finding from 1 review

Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.79 [0.61, 1.03]
1 study · 95 participants
Low

Subintimal angioplasty with stenting vs remote endarterectomy

Clinical improvement: ABI improvement Significant postexercise ABI improvement · 95 people with Rutherford 3 to 5 TASC‐II D lesions

Subintimal angioplasty with stenting showed no clear difference in clinical improvement: ABI improvement Significant postexercise ABI… compared with remote endarterectomy (low certainty).

1 finding from 1 review

Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.86 [0.68, 1.08]
1 study · 95 participants
Low

Subintimal angioplasty with stenting vs remote endarterectomy

Technical success · 95 people with Rutherford 3 to 5 TASC‐II D lesions

Subintimal angioplasty with stenting showed no clear difference in technical success rate compared with remote endarterectomy (low certainty).

1 finding from 1 review

Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.97 [0.88, 1.07]
1 study · 95 participants
Low

Subintimal angioplasty with stenting vs remote endarterectomy

months' patency rate · 95 people with Rutherford 3 to 5 TASC‐II D lesions

Subintimal angioplasty with stenting showed no clear difference in months' patency rate compared with remote endarterectomy (low certainty).

3 findings from 1 review

Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.75 [0.57, 1]
1 study · 95 participants
Low
Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.74 [0.55, 1]
1 study · 95 participants
Low
Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.76 [0.52, 1.11]
1 study · 95 participants
Low

Subintimal angioplasty with stenting vs remote endarterectomy

Limb salvage · 95 people with Rutherford 3 to 5 TASC‐II D lesions

Subintimal angioplasty with stenting showed no clear difference in months' limb salvage rate compared with remote endarterectomy (low certainty).

1 finding from 1 review

Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.97 [0.9, 1.05]
1 study · 95 participants
Low

Subintimal angioplasty with stenting vs remote endarterectomy

Complications · 95 people with Rutherford 3 to 5 TASC‐II D lesions

Subintimal angioplasty with stenting showed no clear difference in complications compared with remote endarterectomy (low certainty).

1 finding from 1 review

Subintimal angioplasty for lower limb arterial chronic total occlusions 2016 · Cochrane Headline outcomes only
RR 0.77 [0.14, 4.42]
1 study · 95 participants
Low

Drug‐eluting balloon vs uncoated balloon angioplasty at 12 months

Amputation · people with peripheral arterial disease of the lower limbs

Drug‐eluting balloon showed no clear difference in amputation compared with uncoated balloon angioplasty at 12 months (high certainty).

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs 2016 · Cochrane Headline outcomes only
OR 1.56 [0.73, 3.33]
9 studies · 1649 participants
High

Drug‐eluting balloon vs uncoated balloon angioplasty at 12 months

Primary vessel patency · people with peripheral arterial disease of the lower limbs

Drug‐eluting balloon leads to higher primary vessel patency compared with uncoated balloon angioplasty at 12 months (high certainty).

1 finding from 1 review

Drug‐eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs 2016 · Cochrane Headline outcomes only
OR 1.92 [1.45, 2.56]
3 studies · 882 participants
High